Correlation Between Mersana Therapeutics and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mersana Therapeutics and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mersana Therapeutics and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mersana Therapeutics and Pliant Therapeutics, you can compare the effects of market volatilities on Mersana Therapeutics and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mersana Therapeutics with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mersana Therapeutics and Pliant Therapeutics.
Diversification Opportunities for Mersana Therapeutics and Pliant Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Mersana and Pliant is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Mersana Therapeutics and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Mersana Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mersana Therapeutics are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Mersana Therapeutics i.e., Mersana Therapeutics and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Mersana Therapeutics and Pliant Therapeutics
Given the investment horizon of 90 days Mersana Therapeutics is expected to generate 2.66 times more return on investment than Pliant Therapeutics. However, Mersana Therapeutics is 2.66 times more volatile than Pliant Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 204.00 in Mersana Therapeutics on August 28, 2024 and sell it today you would lose (4.00) from holding Mersana Therapeutics or give up 1.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Mersana Therapeutics vs. Pliant Therapeutics
Performance |
| Timeline |
| Mersana Therapeutics |
| Pliant Therapeutics |
Mersana Therapeutics and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mersana Therapeutics and Pliant Therapeutics
The main advantage of trading using opposite Mersana Therapeutics and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mersana Therapeutics position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
| Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |